Cargando…

Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19

INTRODUCTION: Host immune response to the coronavirus disease 2019 (COVID-19) is variable and can induce a dysregulated inflammatory response associated with venous and arterial thrombosis called COVID-19 associated coagulopathy (CAC). During septic shock, inflammatory reaction generates endothelial...

Descripción completa

Detalles Bibliográficos
Autores principales: De Poortere, J., Dechamps, M., Laterre, P.F., Octave, M., Ginion, A., Robaux, V., Pirotton, L., Bodart, J., Gerard, L., Gruson, D., Van Dievoet, M.A., Douxfils, J., Derive, M., Gatto, L., Martin, M., Bouzin, C., Castanares-Zapatero, D., Bertrand, L., Horman, S., Beauloye, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2021
Materias:
342
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127522/
http://dx.doi.org/10.1016/j.acvdsp.2021.04.089
_version_ 1783693964924157952
author De Poortere, J.
Dechamps, M.
Laterre, P.F.
Octave, M.
Ginion, A.
Robaux, V.
Pirotton, L.
Bodart, J.
Gerard, L.
Gruson, D.
Van Dievoet, M.A.
Douxfils, J.
Derive, M.
Gatto, L.
Martin, M.
Bouzin, C.
Castanares-Zapatero, D.
Bertrand, L.
Horman, S.
Beauloye, C.
author_facet De Poortere, J.
Dechamps, M.
Laterre, P.F.
Octave, M.
Ginion, A.
Robaux, V.
Pirotton, L.
Bodart, J.
Gerard, L.
Gruson, D.
Van Dievoet, M.A.
Douxfils, J.
Derive, M.
Gatto, L.
Martin, M.
Bouzin, C.
Castanares-Zapatero, D.
Bertrand, L.
Horman, S.
Beauloye, C.
author_sort De Poortere, J.
collection PubMed
description INTRODUCTION: Host immune response to the coronavirus disease 2019 (COVID-19) is variable and can induce a dysregulated inflammatory response associated with venous and arterial thrombosis called COVID-19 associated coagulopathy (CAC). During septic shock, inflammatory reaction generates endothelial activation and procoagulant state with microvascular thrombi inducing disseminated intravascular coagulation (DIC). Although CAC and DIC induce altered coagulation responses, their clinical outcomes are different. OBJECTIVE: We investigated and compared coagulopathy between septic shock and critical COVID-19 patients. METHOD: Septic shock patients were diagnosed following the Survival Sepsis Campaign guidelines. COVID-19 patients were admitted in intensive care unit (ICU) for severe acute respiratory distress syndrome. Both were included in the study within 2 days after admission. Biomarkers were measured by ELISA from patient's plasma. RESULTS: We observed an increase in vWF and TFPI in both septic and COVID-19 patients compared to controls, highlighting endothelial damage. Interestingly, circulating TF was only elevated in COVID-19 patients. Platelet activation differed between the two cohorts of patients. P-selectin and TLT-1 were specifically heightened in septic shock whereas CD40L was only augmented in COVID-19. Coagulation markers were increased in a disease-dependent way, with PAI-1, tPA and D-Dimers higher in septic shock and fibrinogen level, higher in COVID-19. DISCUSSION: COVID-19 patients had longer length-of-stay with more pronounced respiratory failure. This strong lung disruption overtime induced plasmatic TF release with sustained inflammatory response characterized by sCD40L and fibrinogen secretion. Given the similarities between COVID-19 and septic shock regarding fibrinolysis and coagulation, but not platelet activation, endothelium seems to play a central role in COVID-19 and might explain the differences between CAC and DIC.
format Online
Article
Text
id pubmed-8127522
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Masson SAS
record_format MEDLINE/PubMed
spelling pubmed-81275222021-05-18 Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 De Poortere, J. Dechamps, M. Laterre, P.F. Octave, M. Ginion, A. Robaux, V. Pirotton, L. Bodart, J. Gerard, L. Gruson, D. Van Dievoet, M.A. Douxfils, J. Derive, M. Gatto, L. Martin, M. Bouzin, C. Castanares-Zapatero, D. Bertrand, L. Horman, S. Beauloye, C. Archives of Cardiovascular Diseases. Supplements 342 INTRODUCTION: Host immune response to the coronavirus disease 2019 (COVID-19) is variable and can induce a dysregulated inflammatory response associated with venous and arterial thrombosis called COVID-19 associated coagulopathy (CAC). During septic shock, inflammatory reaction generates endothelial activation and procoagulant state with microvascular thrombi inducing disseminated intravascular coagulation (DIC). Although CAC and DIC induce altered coagulation responses, their clinical outcomes are different. OBJECTIVE: We investigated and compared coagulopathy between septic shock and critical COVID-19 patients. METHOD: Septic shock patients were diagnosed following the Survival Sepsis Campaign guidelines. COVID-19 patients were admitted in intensive care unit (ICU) for severe acute respiratory distress syndrome. Both were included in the study within 2 days after admission. Biomarkers were measured by ELISA from patient's plasma. RESULTS: We observed an increase in vWF and TFPI in both septic and COVID-19 patients compared to controls, highlighting endothelial damage. Interestingly, circulating TF was only elevated in COVID-19 patients. Platelet activation differed between the two cohorts of patients. P-selectin and TLT-1 were specifically heightened in septic shock whereas CD40L was only augmented in COVID-19. Coagulation markers were increased in a disease-dependent way, with PAI-1, tPA and D-Dimers higher in septic shock and fibrinogen level, higher in COVID-19. DISCUSSION: COVID-19 patients had longer length-of-stay with more pronounced respiratory failure. This strong lung disruption overtime induced plasmatic TF release with sustained inflammatory response characterized by sCD40L and fibrinogen secretion. Given the similarities between COVID-19 and septic shock regarding fibrinolysis and coagulation, but not platelet activation, endothelium seems to play a central role in COVID-19 and might explain the differences between CAC and DIC. Published by Elsevier Masson SAS 2021-05 2021-05-17 /pmc/articles/PMC8127522/ http://dx.doi.org/10.1016/j.acvdsp.2021.04.089 Text en Copyright © 2021 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 342
De Poortere, J.
Dechamps, M.
Laterre, P.F.
Octave, M.
Ginion, A.
Robaux, V.
Pirotton, L.
Bodart, J.
Gerard, L.
Gruson, D.
Van Dievoet, M.A.
Douxfils, J.
Derive, M.
Gatto, L.
Martin, M.
Bouzin, C.
Castanares-Zapatero, D.
Bertrand, L.
Horman, S.
Beauloye, C.
Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
title Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
title_full Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
title_fullStr Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
title_full_unstemmed Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
title_short Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
title_sort head-to-head comparison of cytokines storm-coagulopathy in septic shock and covid-19
topic 342
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127522/
http://dx.doi.org/10.1016/j.acvdsp.2021.04.089
work_keys_str_mv AT depoorterej headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT dechampsm headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT laterrepf headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT octavem headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT giniona headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT robauxv headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT pirottonl headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT bodartj headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT gerardl headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT grusond headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT vandievoetma headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT douxfilsj headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT derivem headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT gattol headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT martinm headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT bouzinc headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT castanareszapaterod headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT bertrandl headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT hormans headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19
AT beauloyec headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19